Stock Research for CNAT


Featured Broker: Ally Invest

Get the due diligence for another stock.


CNAT Stock Chart & Research Data

The CNAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CNAT Due diligence Resources & Stock Charts

The CNAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CNAT Detailed Price Forecast - CNN Money CNN View CNAT Detailed Summary - Google Finance
Yahoo View CNAT Detailed Summary - Yahoo! Finance Zacks View CNAT Stock Research & Analysis -

Stock Analysis

TradeIdeas View CNAT Trends & Analysis - Trade-Ideas Barrons View CNAT Major Holders - Barrons
NASDAQ View CNAT Call Transcripts - NASDAQ Seeking View CNAT Breaking News & Analysis - Seeking Alpha
Spotlight View CNAT Annual Report - OTC Report View CNAT OTC Short Report -
TradeKing View CNAT Fundamentals - TradeKing Charts View CNAT SEC Filings - Bar Chart
WSJ View Historical Prices for CNAT - The WSJ Morningstar View Performance/Total Return for CNAT - Morningstar
MarketWatch View the Analyst Estimates for CNAT - MarketWatch CNBC View the Earnings History for CNAT - CNBC
StockMarketWatch View the CNAT Earnings - StockMarketWatch MacroAxis View CNAT Buy or Sell Recommendations - MacroAxis
Bullish View the CNAT Bullish Patterns - American Bulls Short Pains View CNAT Short Pain Metrics -

Social Media Mentions

StockTwits View CNAT Stock Mentions - StockTwits PennyStocks View CNAT Stock Mentions - PennyStockTweets
Twitter View CNAT Stock Mentions - Twitter Invest Hub View CNAT Investment Forum News - Investor Hub
Yahoo View CNAT Stock Mentions - Yahoo! Message Board Seeking Alpha View CNAT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CNAT - Insider Cow View Insider Transactions for CNAT - Insider Cow
CNBC View CNAT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CNAT - OTC Markets
Yahoo View Insider Transactions for CNAT - Yahoo! Finance NASDAQ View Institutional Holdings for CNAT - NASDAQ

Stock Charts

FinViz View CNAT Stock Insight & Charts - StockCharts View CNAT Investment Charts -
BarChart View CNAT Stock Overview & Charts - BarChart Trading View View CNAT User Generated Charts - Trading View

Latest Financial News for CNAT

Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension
Posted on Thursday September 20, 2018

Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, will host an invitation-only symposium on portal hypertension for institutional investors and research analysts on Thursday, September 27, 2018, from 4:30 p.m. to 6:00 p.m. ET in New York. Guadalupe Garcia-Tsao, M.D., Professor of Medicine in the Section of Digestive Diseases at Yale School of Medicine, Director of the Clinical and Translational Core at Yale Liver Center, and Chief of the Section of Digestive Diseases at the Veterans Administration-Connecticut Health Care System, will address the clinical importance of portal hypertension.

Today's Research Reports on Trending Tickers: Conatus Pharmaceuticals and INSYS Therapeutics
Posted on Wednesday September 19, 2018

NEW YORK, NY / ACCESSWIRE / September 19, 2018 / U.S. markets closed up Tuesday on the strength of upbeat corporate earnings and strong economic data. On Tuesday, China announced tariffs of between 5 to ...

Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences
Posted on Wednesday September 19, 2018

Conatus Pharmaceuticals Inc. (CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease (September 26-27 in New York), senior management will conduct a series of scheduled meetings with investment professionals. At the Roth Capital Partners Battle of the NASH Thrones Investor Conference (October 17 in New York), senior management will conduct a series of scheduled meetings with investment professionals and participate in a panel discussion on fibrotic, inflammatory and metabolic agents.

Who Owns Most Of Conatus Pharmaceuticals Inc (NASDAQ:CNAT)?
Posted on Tuesday September 18, 2018

Every investor in Conatus Pharmaceuticals Inc (NASDAQ:CNAT) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to seeRead More...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.